US4479795A
(en)
*
|
1979-06-29 |
1984-10-30 |
The Procter & Gamble Company |
Antimicrobial polymer compositions
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US5366738A
(en)
*
|
1982-07-29 |
1994-11-22 |
Merck & Co., Inc. |
Controlled release drug dispersion delivery device
|
US4709996A
(en)
*
|
1982-09-30 |
1987-12-01 |
Michelson Paul E |
Fluid lens
|
US4466705A
(en)
*
|
1982-09-30 |
1984-08-21 |
Michelson Paul E |
Fluid lens
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
GB8305797D0
(en)
*
|
1983-03-02 |
1983-04-07 |
Graham N B |
Hydrogel-containing envelopes
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
AT394944B
(de)
*
|
1983-05-11 |
1992-07-27 |
Alza Corp |
Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
NZ206600A
(en)
*
|
1983-05-11 |
1987-01-23 |
Alza Corp |
Osmotic drug delivery device
|
USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4781714A
(en)
*
|
1983-11-02 |
1988-11-01 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
AU591171B2
(en)
*
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4772474A
(en)
*
|
1985-08-09 |
1988-09-20 |
Alza Corporation |
Dispenser with internal arrangement of lamina means for dispensing beneficial agent
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4927633A
(en)
*
|
1984-03-19 |
1990-05-22 |
Alza Corporation |
Dispenser for delivering drug to livestock
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4717566A
(en)
*
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4624945A
(en)
*
|
1984-03-19 |
1986-11-25 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4595583A
(en)
*
|
1984-03-19 |
1986-06-17 |
Alza Corporation |
Delivery system controlled administration of beneficial agent to ruminants
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
US4678467A
(en)
*
|
1984-03-21 |
1987-07-07 |
Alza Corporation |
Dispenser comprising capsule with volume displacing member
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
GB2155889B
(en)
*
|
1984-03-21 |
1988-03-02 |
Alza Corp |
Dispenser-capsule
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4624847A
(en)
*
|
1985-04-22 |
1986-11-25 |
Alza Corporation |
Drug delivery device for programmed delivery of beneficial drug
|
US4627971A
(en)
*
|
1985-04-22 |
1986-12-09 |
Alza Corporation |
Osmotic device with self-sealing passageway
|
US4717568A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Laminar arrangement for increasing delivery of beneficial agent from dispenser
|
US4717718A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Device for the controlled delivery of a beneficial agent
|
US4955881A
(en)
*
|
1985-08-16 |
1990-09-11 |
Alza Corporation |
Ruminant dispensing device
|
US4643731A
(en)
*
|
1985-08-16 |
1987-02-17 |
Alza Corporation |
Means for providing instant agent from agent dispensing system
|
US5098425A
(en)
*
|
1985-08-16 |
1992-03-24 |
Alza Corporation |
Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
|
US4883667A
(en)
*
|
1985-08-16 |
1989-11-28 |
Alza Corporation |
Process for forming dispensing device
|
US4704118A
(en)
*
|
1985-08-16 |
1987-11-03 |
Alza Corporation |
Ruminant dispensing device with thermo-activated memory
|
US4865598A
(en)
*
|
1985-08-16 |
1989-09-12 |
Alza Corporation |
Dispensing system for administering beneficial agent
|
US4966767A
(en)
*
|
1985-08-16 |
1990-10-30 |
Alza Corporation |
Ruminant dispensing device comprising agent displacement member
|
US4963141A
(en)
*
|
1985-08-16 |
1990-10-16 |
Alza Corporation |
Dispensing system for administering beneficial agent formulation to ruminants
|
US4871544A
(en)
*
|
1985-08-16 |
1989-10-03 |
Alza Corporation |
Ruminant dispensing device
|
US5008288A
(en)
*
|
1986-01-06 |
1991-04-16 |
Alfred Stracher |
Carnitine directed pharmaceutical agents
|
US4866040A
(en)
*
|
1986-01-06 |
1989-09-12 |
Alfred Stracher |
Aminocarnitine directed pharmaceutical agents
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4723957A
(en)
*
|
1986-02-07 |
1988-02-09 |
Alza Corp. |
System for delivering drug with enhanced bioacceptability
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4865845A
(en)
*
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
US4863456A
(en)
*
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
GB2189702B
(en)
*
|
1986-04-30 |
1989-10-18 |
Alza Corp |
Dosage form with improved delivery capability
|
US4960416A
(en)
*
|
1986-04-30 |
1990-10-02 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
US4755180A
(en)
*
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
US4983400A
(en)
*
|
1986-06-16 |
1991-01-08 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
CH668187A5
(de)
*
|
1986-08-07 |
1988-12-15 |
Ciba Geigy Ag |
Therapeutisches system mit systemischer wirkung.
|
USRE34990E
(en)
*
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
ATE72111T1
(de)
*
|
1987-01-14 |
1992-02-15 |
Ciba Geigy Ag |
Therapeutisches system fuer schwerloesliche wirkstoffe.
|
JPS63180224A
(ja)
*
|
1987-01-21 |
1988-07-25 |
Matsushita Electric Ind Co Ltd |
無線機のアンテナ回路
|
US4892778A
(en)
*
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US4940465A
(en)
*
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US4876093A
(en)
*
|
1987-07-02 |
1989-10-24 |
Alza Corporation |
Dispenser with dispersing member for delivering beneficial agent
|
US4824675A
(en)
*
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4915949A
(en)
*
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4891223A
(en)
*
|
1987-09-03 |
1990-01-02 |
Air Products And Chemicals, Inc. |
Controlled release delivery coating formulation for bioactive substances
|
US4950486A
(en)
*
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4946687A
(en)
*
|
1987-10-02 |
1990-08-07 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4816263A
(en)
*
|
1987-10-02 |
1989-03-28 |
Alza Corporation |
Dosage form for treating cardiovascular diseases comprising isradipine
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5030456A
(en)
*
|
1988-11-07 |
1991-07-09 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US5376383A
(en)
*
|
1988-11-21 |
1994-12-27 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma-cholesterol levels
|
US4997658A
(en)
*
|
1988-11-21 |
1991-03-05 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma cholesterol levels
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
JP2885858B2
(ja)
*
|
1989-01-31 |
1999-04-26 |
イー・ペー・アー・インテルナチオナーレ・ファルマ・アゲンチュル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
有効物質の制御放出システムおよびその製造方法
|
DD295760A5
(de)
*
|
1989-01-31 |
1991-11-14 |
Martin-Luther-Universitaet Halle Wittenberg,De |
Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
|
US6200600B1
(en)
*
|
1989-02-16 |
2001-03-13 |
Btg International Limited |
Controlled delay release device
|
US5181505A
(en)
*
|
1989-03-08 |
1993-01-26 |
Lew Chel W |
Method and apparatus for delivery of a medicament in the oral cavity
|
US5002540A
(en)
*
|
1989-05-22 |
1991-03-26 |
Warren Kirschbaum |
Intravaginal device and method for delivering a medicament
|
US5776493A
(en)
*
|
1989-07-14 |
1998-07-07 |
Alza Corporation |
Oral osmotic device for delivery of nystatin with hydrogel driving member
|
US5021053A
(en)
*
|
1989-07-14 |
1991-06-04 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5030216A
(en)
*
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5660851A
(en)
*
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5128145A
(en)
*
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5057321A
(en)
*
|
1990-06-13 |
1991-10-15 |
Alza Corporation |
Dosage form comprising drug and maltodextrin
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
NZ238867A
(en)
*
|
1990-07-12 |
1993-08-26 |
Alza Corp |
Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
|
US5147654A
(en)
*
|
1990-07-23 |
1992-09-15 |
Alza Corporation |
Oral osmotic device for delivering nicotine
|
ATE106015T1
(de)
*
|
1990-09-28 |
1994-06-15 |
Pfizer |
Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5593852A
(en)
|
1993-12-02 |
1997-01-14 |
Heller; Adam |
Subcutaneous glucose electrode
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5208037A
(en)
*
|
1991-04-22 |
1993-05-04 |
Alza Corporation |
Dosage forms comprising polymers comprising different molecular weights
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5252338A
(en)
*
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US5190765A
(en)
*
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
MX9205850A
(es)
*
|
1991-10-10 |
1993-06-01 |
Alza Corp |
Dispositivos de surtido osmotico de farmaco con materiales de pared hidrofobicos
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
US5543154A
(en)
*
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5248310A
(en)
*
|
1992-03-27 |
1993-09-28 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5512299A
(en)
*
|
1992-03-30 |
1996-04-30 |
Alza Corporation |
Method of treating oral inflammatory disease
|
US5869097A
(en)
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
US5573776A
(en)
*
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
HU213407B
(en)
*
|
1993-12-09 |
1997-06-30 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tablet with diffusive-osmotic release
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
GB9326267D0
(en)
*
|
1993-12-23 |
1994-02-23 |
Scherer Corp R P |
Expulsion of material
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5540665A
(en)
*
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5460826A
(en)
*
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US5529787A
(en)
*
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
IE70735B1
(en)
*
|
1994-08-15 |
1996-12-11 |
Elan Med Tech |
Orally administrable delivery device
|
US5582591A
(en)
*
|
1994-09-02 |
1996-12-10 |
Delab |
Delivery of solid drug compositions
|
US5837276A
(en)
*
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5614578A
(en)
*
|
1994-10-28 |
1997-03-25 |
Alza Corporation |
Injection-molded dosage form
|
US5582838A
(en)
*
|
1994-12-22 |
1996-12-10 |
Merck & Co., Inc. |
Controlled release drug suspension delivery device
|
US5534263A
(en)
*
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5876741A
(en)
*
|
1995-03-30 |
1999-03-02 |
Medlogic Global Corporation |
Chemo-mechanical expansion delivery system
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US6124355A
(en)
*
|
1995-05-22 |
2000-09-26 |
Guittard; George V. |
Oxybutynin therapy
|
US6262115B1
(en)
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5780058A
(en)
*
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
US5840332A
(en)
*
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
ES2168610T3
(es)
*
|
1996-03-12 |
2002-06-16 |
Alza Corp |
Composicion y forma galenica que contiene un antagonista opioide.
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
ZA97976B
(en)
*
|
1996-04-05 |
1997-08-18 |
Alza Corp |
Uniform drug delivery theraphy.
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
PT957899E
(pt)
*
|
1996-08-16 |
2003-07-31 |
Alza Corp |
Forma de dosagem para proporcionar um medicamento numa dose crescente
|
ES2162262T3
(es)
|
1996-10-18 |
2001-12-16 |
Alza Corp |
Dispositivo para la administracion de agentes activos.
|
US6024721A
(en)
*
|
1996-10-18 |
2000-02-15 |
Alza Corporation |
Mixing system for an active agent delivery device
|
ATE202272T1
(de)
*
|
1996-10-18 |
2001-07-15 |
Alza Corp |
Vorrichtung mit mehreren strömungspfaden zur oralen verabreichung von boluseinheiten
|
US6361796B1
(en)
*
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
AU721653B2
(en)
*
|
1996-10-25 |
2000-07-13 |
Supernus Pharmaceuticals, Inc. |
Soluble form osmotic dose delivery system
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
EP1782798A3
(de)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Darreichungsform mit ansteigender Dosisfreisetzung
|
CN1182839C
(zh)
*
|
1996-11-25 |
2005-01-05 |
阿尔萨公司 |
递增剂量的剂型
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20030100532A1
(en)
*
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
US5985324A
(en)
*
|
1997-05-16 |
1999-11-16 |
Alza Corporation |
Flow controller configurations for an active agent delivery device
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
WO1999012526A1
(en)
|
1997-09-09 |
1999-03-18 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
US7060734B1
(en)
|
1997-09-09 |
2006-06-13 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
ES2216327T3
(es)
|
1997-11-10 |
2004-10-16 |
G.D. SEARLE & CO. |
Uso de iminoazucares alquilados para tratar la resistencia a multiples a farmacos.
|
PT1035834E
(pt)
|
1997-12-05 |
2002-09-30 |
Alza Corp |
Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
AU1623099A
(en)
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
CA2319713C
(en)
|
1998-02-12 |
2012-06-26 |
G.D. Searle & Co. |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
US6134461A
(en)
|
1998-03-04 |
2000-10-17 |
E. Heller & Company |
Electrochemical analyte
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US6365183B1
(en)
|
1998-05-07 |
2002-04-02 |
Alza Corporation |
Method of fabricating a banded prolonged release active agent dosage form
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US7890176B2
(en)
*
|
1998-07-06 |
2011-02-15 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating chronic pelvic pain
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
ES2238843T3
(es)
|
1998-07-24 |
2005-09-01 |
Seo Hong Yoo |
Disoluciones acuosas transparentes de acidos biliares.
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
US7303768B2
(en)
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
JP2002524407A
(ja)
*
|
1998-09-09 |
2002-08-06 |
アルザ・コーポレーション |
液体配合物を含んで成る剤形
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6087396A
(en)
*
|
1998-10-05 |
2000-07-11 |
Situs Corporation |
Oxybutynin formulations and method of use
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
JP2002532406A
(ja)
*
|
1998-12-17 |
2002-10-02 |
アルザ・コーポレーション |
複合コーティングによる液体充填ゼラチンカプセルの放出制御システムへの変換
|
PL195871B1
(pl)
|
1998-12-18 |
2007-11-30 |
Alza Corp |
Urządzenie do przezskórnego dostarczania nikotyny
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
CA2358296A1
(en)
*
|
1999-01-05 |
2000-07-13 |
Anthony P. Adamis |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
ATE433318T1
(de)
|
1999-02-10 |
2009-06-15 |
Pfizer Prod Inc |
Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
DE60039729D1
(de)
|
1999-02-12 |
2008-09-11 |
United Therapeutics Corp |
N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
|
EP1173161A2
(de)
|
1999-02-12 |
2002-01-23 |
G.D. SEARLE & CO. |
Verwendung von glucamin derivaten zur behandlung von hepatitis infektionen
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US8545880B2
(en)
*
|
1999-02-26 |
2013-10-01 |
Andrx Pharmaceuticals, Llc |
Controlled release oral dosage form
|
US6210716B1
(en)
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217896B1
(en)
*
|
1999-04-01 |
2001-04-17 |
Uab Research Foundation |
Conjunctival inserts for topical delivery of medication or lubrication
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US6287870B1
(en)
*
|
1999-08-20 |
2001-09-11 |
Robert A. Levine |
Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
CO5210862A1
(es)
|
1999-09-15 |
2002-10-30 |
Alza Corp |
Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
|
US6387325B1
(en)
*
|
1999-10-08 |
2002-05-14 |
Becton Dickinson & Company |
Assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
EP1473003B1
(de)
|
1999-10-21 |
2008-11-19 |
Alcon, Inc. |
Medikamentenzuführeinrichtung
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
AU775149B2
(en)
|
1999-10-21 |
2004-07-22 |
Alcon Inc. |
Sub-tenon drug delivery
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
KR100523127B1
(ko)
*
|
1999-12-23 |
2005-10-20 |
화이자 프로덕츠 인코포레이티드 |
하이드로겔계 약물 투여 형태
|
WO2001047498A2
(en)
|
1999-12-23 |
2001-07-05 |
Pfizer Products Inc. |
Hydrogel-driven layered drug dosage form comprising sertraline
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
CN100558407C
(zh)
*
|
2000-02-04 |
2009-11-11 |
柳署弘 |
制备含有胆汁酸的澄清水溶液剂型
|
EP1261339A1
(de)
*
|
2000-02-14 |
2002-12-04 |
Pharmacia Corporation |
Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitolverbindungen zur behandlung von hepatitisvirusinfektionen
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
US6582441B1
(en)
|
2000-02-24 |
2003-06-24 |
Advanced Bionics Corporation |
Surgical insertion tool
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US7989436B2
(en)
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
WO2001080831A2
(en)
|
2000-04-27 |
2001-11-01 |
Verion Inc. |
Zero order release and temperature-controlled microcapsules and process for the preparation thereof
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
JP2004514702A
(ja)
|
2000-11-29 |
2004-05-20 |
オキュレックス ファーマシューティカルズ, インコーポレイテッド |
眼における移植拒絶を予防するための眼内インプラント
|
CA2429945A1
(en)
*
|
2000-11-29 |
2002-06-06 |
Durect Corporation |
Devices and methods for controlled delivery from a drug delivery device
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US7493172B2
(en)
*
|
2001-01-30 |
2009-02-17 |
Boston Scientific Neuromodulation Corp. |
Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
|
US20060064140A1
(en)
*
|
2001-01-30 |
2006-03-23 |
Whitehurst Todd K |
Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
|
US20050143789A1
(en)
*
|
2001-01-30 |
2005-06-30 |
Whitehurst Todd K. |
Methods and systems for stimulating a peripheral nerve to treat chronic pain
|
IN190699B
(de)
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
CA2441064A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Andrx Corporation |
Controlled release sulfonylurea formulation
|
US7041468B2
(en)
|
2001-04-02 |
2006-05-09 |
Therasense, Inc. |
Blood glucose tracking apparatus and methods
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US7563255B2
(en)
|
2001-05-03 |
2009-07-21 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
EP2316394B1
(de)
|
2001-06-12 |
2016-11-23 |
The Johns Hopkins University |
Reservoirvorrichtung für die intraokulare Arzneimittelabgabe
|
DE10129725A1
(de)
*
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US20040180087A1
(en)
*
|
2001-06-21 |
2004-09-16 |
Boyong Li |
Stable controlled release pharmaceutical compositions containing pravastatin
|
DK1385452T3
(da)
*
|
2001-07-23 |
2007-01-15 |
Alcon Inc |
Anordning til tilförsel af et ophthalmisk medikament
|
PT1409065E
(pt)
|
2001-07-23 |
2007-03-30 |
Alcon Inc |
Dispositivo de administração de fármacos oftálmicos
|
US20030091634A1
(en)
*
|
2001-09-14 |
2003-05-15 |
Pawan Seth |
Delayed release tablet of venlafaxin
|
JP2005529059A
(ja)
*
|
2001-09-28 |
2005-09-29 |
マクニール−ピーピーシー・インコーポレイテッド |
改質した放出用の投薬形態
|
US20030153864A1
(en)
*
|
2001-10-16 |
2003-08-14 |
Bernard Chaffringeon |
Disposable device and method for transferring an active liquid into a body cavity
|
US20030185882A1
(en)
*
|
2001-11-06 |
2003-10-02 |
Vergez Juan A. |
Pharmaceutical compositions containing oxybutynin
|
US8329217B2
(en)
*
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
US7183321B2
(en)
*
|
2001-12-17 |
2007-02-27 |
Bristol-Myers Squibb Company |
Antidiabetic formulation and method
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US7613491B2
(en)
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8858434B2
(en)
|
2004-07-13 |
2014-10-14 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
KR20040088519A
(ko)
|
2002-02-22 |
2004-10-16 |
뉴 리버 파마슈티칼스, 인크. |
활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
MXPA04009701A
(es)
*
|
2002-04-05 |
2005-05-27 |
Penwest Pharmaceuticals Co |
Formulaciones de metoprolol de liberacion sostenida.
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US6733526B2
(en)
|
2002-04-25 |
2004-05-11 |
Advanced Medical Optics, Inc. |
Method of improving adherence and centering of intra-corneal implants on corneal bed
|
CA2483655A1
(en)
*
|
2002-04-29 |
2003-11-13 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US7328706B2
(en)
*
|
2002-05-06 |
2008-02-12 |
Dynamic Mouth Devices Llc |
Therapeutic and protective dental device useful as an intra-oral delivery system
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7151961B1
(en)
*
|
2002-05-24 |
2006-12-19 |
Advanced Bionics Corporation |
Treatment of movement disorders by brain stimulation
|
AU2003245345A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
US20040043067A1
(en)
*
|
2002-06-19 |
2004-03-04 |
Salamone Joseph C. |
Fluorosiloxane matrix controlled diffusion drug delivery systems
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20050175697A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Novel drug compositions and dosage forms of topiramate
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US7254449B2
(en)
*
|
2002-07-31 |
2007-08-07 |
Advanced Bionics Corp |
Systems and methods for providing power to one or more implantable devices
|
CA2497867A1
(en)
|
2002-09-06 |
2004-03-18 |
Durect Corporation |
Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
|
US20060009739A1
(en)
*
|
2002-09-06 |
2006-01-12 |
Durect Corporation |
Implantable flow regulator with failsafe mode and reserve drug supply
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
AU2003270778B2
(en)
*
|
2002-09-20 |
2009-10-08 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
KR20050083874A
(ko)
*
|
2002-10-31 |
2005-08-26 |
알자 코포레이션 |
액상 제제의 방출을 증진시키는 제형
|
US7381184B2
(en)
|
2002-11-05 |
2008-06-03 |
Abbott Diabetes Care Inc. |
Sensor inserter assembly
|
GB2395126A
(en)
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
US7811231B2
(en)
|
2002-12-31 |
2010-10-12 |
Abbott Diabetes Care Inc. |
Continuous glucose monitoring system and methods of use
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
WO2004064772A2
(en)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methods and dosage forms with modified viscosity layers
|
JP3811127B2
(ja)
*
|
2003-01-30 |
2006-08-16 |
株式会社東芝 |
情報記録装置及び情報記録方法
|
KR20050123097A
(ko)
*
|
2003-02-11 |
2005-12-29 |
알자 코포레이션 |
변형된 층 형상을 갖는 방법 및 제형
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
MXPA05010871A
(es)
*
|
2003-04-11 |
2005-11-25 |
Barr Lab Inc |
Metodos para administrar estrogenos y progestinas.
|
US20040213850A1
(en)
*
|
2003-04-25 |
2004-10-28 |
Eleni Dokou |
Sustained release delivery of a thrombin inhibitor
|
US20070083240A1
(en)
*
|
2003-05-08 |
2007-04-12 |
Peterson David K L |
Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
|
EP2390262A1
(de)
|
2003-05-16 |
2011-11-30 |
Intermune, Inc. |
Synthetische Chemokinrezeptorliganden und Verwendungsverfahren dafür
|
US8066639B2
(en)
|
2003-06-10 |
2011-11-29 |
Abbott Diabetes Care Inc. |
Glucose measuring device for use in personal area network
|
US20040253293A1
(en)
*
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
EP2112920B1
(de)
|
2003-06-26 |
2018-07-25 |
Intellipharmaceutics Corp. |
Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
|
CN1805719A
(zh)
*
|
2003-07-10 |
2006-07-19 |
爱尔康公司 |
眼药输送装置
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2007120442A2
(en)
|
2003-07-25 |
2007-10-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US7774145B2
(en)
|
2003-08-01 |
2010-08-10 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20190357827A1
(en)
|
2003-08-01 |
2019-11-28 |
Dexcom, Inc. |
Analyte sensor
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
CA2534920A1
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
US20140121989A1
(en)
|
2003-08-22 |
2014-05-01 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
AU2004268661A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
JP5670609B2
(ja)
|
2003-09-26 |
2015-02-18 |
アルザ・コーポレーシヨン |
有効成分の制御送達のためのorosプッシュ−スティック
|
AU2004314693B2
(en)
|
2003-09-26 |
2011-04-07 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
US20050260268A1
(en)
*
|
2003-09-26 |
2005-11-24 |
Modi Nishit B |
Methods and dosage forms for controlled delivery of alprazolam
|
CA2540059C
(en)
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US20050118246A1
(en)
*
|
2003-10-31 |
2005-06-02 |
Wong Patrick S. |
Dosage forms and layered deposition processes for fabricating dosage forms
|
RU2006118801A
(ru)
*
|
2003-10-31 |
2007-12-10 |
Алза Корпорейшн (Us) |
Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
|
US7299082B2
(en)
|
2003-10-31 |
2007-11-20 |
Abbott Diabetes Care, Inc. |
Method of calibrating an analyte-measurement device, and associated methods, devices and systems
|
USD914881S1
(en)
|
2003-11-05 |
2021-03-30 |
Abbott Diabetes Care Inc. |
Analyte sensor electronic mount
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
BRPI0415764A
(pt)
|
2003-11-28 |
2006-12-26 |
Eastman Chem Co |
interpolìmero, produto de reação, métodos para converter uma hidroxila, para preparar uma forma estável de um interpolìmero, para converter um álcool primário, e para tratar um mamìfero necessitado do mesmo, composições para revestimento e farmacêutica oral, dispersão de pigmento, e, artigo
|
EP1711790B1
(de)
|
2003-12-05 |
2010-09-08 |
DexCom, Inc. |
Kalibrationsmethoden für einen kontinuierlich arbeitenden analytsensor
|
US8423114B2
(en)
|
2006-10-04 |
2013-04-16 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US7769461B2
(en)
*
|
2003-12-19 |
2010-08-03 |
Boston Scientific Neuromodulation Corporation |
Skull-mounted electrical stimulation system and method for treating patients
|
CA2550866A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
EP1701706A2
(de)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Neue arzneimittelzusammensetzungen und dosierformen
|
DE602005011928D1
(de)
|
2004-01-20 |
2009-02-05 |
Allergan Inc |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
WO2005089103A2
(en)
|
2004-02-17 |
2005-09-29 |
Therasense, Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US8512738B2
(en)
*
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US8425929B2
(en)
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050267555A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Marnfeldt Goran N |
Engagement tool for implantable medical devices
|
WO2005119524A2
(en)
|
2004-06-04 |
2005-12-15 |
Therasense, Inc. |
Diabetes care host-client architecture and data management system
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20080027513A1
(en)
*
|
2004-07-09 |
2008-01-31 |
Advanced Bionics Corporation |
Systems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical Device
|
BRPI0513243B8
(pt)
*
|
2004-07-12 |
2021-05-25 |
Allergan Inc |
composições oftálmicas e respectivos usos
|
US20060270922A1
(en)
|
2004-07-13 |
2006-11-30 |
Brauker James H |
Analyte sensor
|
US8452368B2
(en)
|
2004-07-13 |
2013-05-28 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7905833B2
(en)
|
2004-07-13 |
2011-03-15 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US7857760B2
(en)
|
2004-07-13 |
2010-12-28 |
Dexcom, Inc. |
Analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8452407B2
(en)
*
|
2004-08-16 |
2013-05-28 |
Boston Scientific Neuromodulation Corporation |
Methods for treating gastrointestinal disorders
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
RU2428987C2
(ru)
*
|
2004-08-30 |
2011-09-20 |
Сео Хонг Ю |
Нейрозащитное действие растворимой урсодезоксихолевой кислоты в моделях фокальной ишемии
|
US7780981B2
(en)
|
2004-09-13 |
2010-08-24 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
EP1809330B1
(de)
*
|
2004-10-15 |
2011-04-27 |
Seo Hong Yoo |
Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
|
WO2006050165A2
(en)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
US9358393B1
(en)
|
2004-11-09 |
2016-06-07 |
Andres M. Lozano |
Stimulation methods and systems for treating an auditory dysfunction
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US7483746B2
(en)
*
|
2004-12-06 |
2009-01-27 |
Boston Scientific Neuromodulation Corp. |
Stimulation of the stomach in response to sensed parameters to treat obesity
|
US9327069B2
(en)
|
2004-12-21 |
2016-05-03 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a medical condition by promoting neural remodeling within the brain
|
US9095713B2
(en)
*
|
2004-12-21 |
2015-08-04 |
Allison M. Foster |
Methods and systems for treating autism by decreasing neural activity within the brain
|
US20060161217A1
(en)
*
|
2004-12-21 |
2006-07-20 |
Jaax Kristen N |
Methods and systems for treating obesity
|
US20070038264A1
(en)
*
|
2004-12-21 |
2007-02-15 |
Jaax Kristen N |
Methods and systems for treating autism
|
WO2006068921A2
(en)
*
|
2004-12-22 |
2006-06-29 |
Alcon, Inc. |
Device for ophthalmic drug delivery
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US8515541B1
(en)
|
2004-12-22 |
2013-08-20 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating post-stroke disorders
|
US9352145B2
(en)
*
|
2004-12-22 |
2016-05-31 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a psychotic disorder
|
US20090105569A1
(en)
|
2006-04-28 |
2009-04-23 |
Abbott Diabetes Care, Inc. |
Introducer Assembly and Methods of Use
|
US8571624B2
(en)
|
2004-12-29 |
2013-10-29 |
Abbott Diabetes Care Inc. |
Method and apparatus for mounting a data transmission device in a communication system
|
US7731657B2
(en)
*
|
2005-08-30 |
2010-06-08 |
Abbott Diabetes Care Inc. |
Analyte sensor introducer and methods of use
|
US9572534B2
(en)
|
2010-06-29 |
2017-02-21 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US9398882B2
(en)
|
2005-09-30 |
2016-07-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor and data processing device
|
US7883464B2
(en)
|
2005-09-30 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Integrated transmitter unit and sensor introducer mechanism and methods of use
|
US9636450B2
(en)
|
2007-02-19 |
2017-05-02 |
Udo Hoss |
Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
|
US8333714B2
(en)
|
2006-09-10 |
2012-12-18 |
Abbott Diabetes Care Inc. |
Method and system for providing an integrated analyte sensor insertion device and data processing unit
|
US7697967B2
(en)
|
2005-12-28 |
2010-04-13 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
US9259175B2
(en)
|
2006-10-23 |
2016-02-16 |
Abbott Diabetes Care, Inc. |
Flexible patch for fluid delivery and monitoring body analytes
|
US8512243B2
(en)
|
2005-09-30 |
2013-08-20 |
Abbott Diabetes Care Inc. |
Integrated introducer and transmitter assembly and methods of use
|
US8029441B2
(en)
|
2006-02-28 |
2011-10-04 |
Abbott Diabetes Care Inc. |
Analyte sensor transmitter unit configuration for a data monitoring and management system
|
US9351669B2
(en)
|
2009-09-30 |
2016-05-31 |
Abbott Diabetes Care Inc. |
Interconnect for on-body analyte monitoring device
|
US10226207B2
(en)
|
2004-12-29 |
2019-03-12 |
Abbott Diabetes Care Inc. |
Sensor inserter having introducer
|
US9788771B2
(en)
|
2006-10-23 |
2017-10-17 |
Abbott Diabetes Care Inc. |
Variable speed sensor insertion devices and methods of use
|
US9743862B2
(en)
|
2011-03-31 |
2017-08-29 |
Abbott Diabetes Care Inc. |
Systems and methods for transcutaneously implanting medical devices
|
IL166114A0
(en)
*
|
2005-01-03 |
2006-01-15 |
Calcident Active Ltd |
Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
|
ATE413864T1
(de)
*
|
2005-01-27 |
2008-11-15 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
EP1685841A1
(de)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
CA2601773A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
US20060185678A1
(en)
*
|
2005-02-03 |
2006-08-24 |
Bronnenkant Lance J |
Devices for delivering agents to a vaginal tract
|
EP1690540A1
(de)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Zusammensetzung enthaltend Ocaperidon
|
US20060185665A1
(en)
*
|
2005-02-22 |
2006-08-24 |
Bachinski Thomas J |
Sauna fireplace
|
US20060194724A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Whitehurst Todd K |
Methods and systems for nerve regeneration
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
US7848803B1
(en)
|
2005-03-14 |
2010-12-07 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US7920915B2
(en)
*
|
2005-11-16 |
2011-04-05 |
Boston Scientific Neuromodulation Corporation |
Implantable stimulator
|
US7853321B2
(en)
*
|
2005-03-14 |
2010-12-14 |
Boston Scientific Neuromodulation Corporation |
Stimulation of a stimulation site within the neck or head
|
US8423155B1
(en)
|
2005-03-14 |
2013-04-16 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
CN101232868A
(zh)
*
|
2005-04-19 |
2008-07-30 |
阿尔扎公司 |
曲马多和加巴喷丁的控释递药剂型
|
US8112240B2
(en)
|
2005-04-29 |
2012-02-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing leak detection in data monitoring and management systems
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
KR20080030637A
(ko)
*
|
2005-06-29 |
2008-04-04 |
알자 코포레이션 |
삼투성 제형에 대하여 감소된 건조 시간을 제공하는반투과성 조성물
|
DE102005031577A1
(de)
*
|
2005-07-06 |
2007-01-11 |
Bayer Healthcare Ag |
Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
|
US9447781B2
(en)
*
|
2005-07-22 |
2016-09-20 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
KR20080033463A
(ko)
|
2005-07-27 |
2008-04-16 |
유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. |
단백질 미스폴딩을 보정하는 작은 화합물 및 그의 용도
|
WO2007019393A2
(en)
*
|
2005-08-04 |
2007-02-15 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070048347A1
(en)
*
|
2005-08-26 |
2007-03-01 |
Laura Bardach |
Intra-oral device for treating obesity
|
US20080314395A1
(en)
|
2005-08-31 |
2008-12-25 |
Theuniversity Of Virginia Patent Foundation |
Accuracy of Continuous Glucose Sensors
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US7684858B2
(en)
*
|
2005-09-21 |
2010-03-23 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for placing an implanted stimulator for stimulating tissue
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
EP1933852B1
(de)
*
|
2005-09-27 |
2018-12-19 |
TissueTech, Inc. |
Amnion-zubereitungen und gereinigte zusammensetzungen und anwendungsverfahren
|
US9521968B2
(en)
|
2005-09-30 |
2016-12-20 |
Abbott Diabetes Care Inc. |
Analyte sensor retention mechanism and methods of use
|
US8880138B2
(en)
|
2005-09-30 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Device for channeling fluid and methods of use
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
DK1934208T3
(da)
|
2005-10-04 |
2011-07-18 |
Bayer Schering Pharma Ag |
Ny polymorf form af 5-chlor-N-({(5S)-2-0x0-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
WO2007044234A1
(en)
*
|
2005-10-07 |
2007-04-19 |
Alza Corporation |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US7766829B2
(en)
|
2005-11-04 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and system for providing basal profile modification in analyte monitoring and management systems
|
EP1948246B1
(de)
|
2005-11-14 |
2017-05-03 |
Theragene Pharmaceuticals, Inc. |
Stammzellenfaktor-therapie für gewebeverletzungen
|
JP5334588B2
(ja)
|
2005-11-28 |
2013-11-06 |
マリナス ファーマシューティカルズ |
ガナキソロン製剤、およびその作製方法、およびその使用
|
KR20080071188A
(ko)
|
2005-11-29 |
2008-08-01 |
스미스클라인 비참 코포레이션 |
치료 방법
|
US7729758B2
(en)
*
|
2005-11-30 |
2010-06-01 |
Boston Scientific Neuromodulation Corporation |
Magnetically coupled microstimulators
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US11298058B2
(en)
|
2005-12-28 |
2022-04-12 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
CA2636034A1
(en)
|
2005-12-28 |
2007-10-25 |
Abbott Diabetes Care Inc. |
Medical device insertion
|
US7610100B2
(en)
*
|
2005-12-30 |
2009-10-27 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating osteoarthritis
|
US7835803B1
(en)
|
2006-01-17 |
2010-11-16 |
Boston Scientific Neuromodulation Corporation |
Lead assemblies with one or more switching networks
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US7736310B2
(en)
|
2006-01-30 |
2010-06-15 |
Abbott Diabetes Care Inc. |
On-body medical device securement
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
US7826879B2
(en)
|
2006-02-28 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Analyte sensors and methods of use
|
US7885698B2
(en)
|
2006-02-28 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Method and system for providing continuous calibration of implantable analyte sensors
|
US8309104B2
(en)
*
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
EP1991110B1
(de)
*
|
2006-03-09 |
2018-11-07 |
DexCom, Inc. |
Systeme und verfahren zur aufbereitung von analytensensordaten
|
US8175710B2
(en)
*
|
2006-03-14 |
2012-05-08 |
Boston Scientific Neuromodulation Corporation |
Stimulator system with electrode array and the method of making the same
|
US7777641B2
(en)
*
|
2006-03-29 |
2010-08-17 |
Advanced Bionics, Llc |
Systems and methods of facilitating communication between a first and second device
|
US9392969B2
(en)
|
2008-08-31 |
2016-07-19 |
Abbott Diabetes Care Inc. |
Closed loop control and signal attenuation detection
|
US7801582B2
(en)
|
2006-03-31 |
2010-09-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management system and methods therefor
|
US7653425B2
(en)
|
2006-08-09 |
2010-01-26 |
Abbott Diabetes Care Inc. |
Method and system for providing calibration of an analyte sensor in an analyte monitoring system
|
US7630748B2
(en)
|
2006-10-25 |
2009-12-08 |
Abbott Diabetes Care Inc. |
Method and system for providing analyte monitoring
|
US8219173B2
(en)
|
2008-09-30 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Optimizing analyte sensor calibration
|
US9675290B2
(en)
|
2012-10-30 |
2017-06-13 |
Abbott Diabetes Care Inc. |
Sensitivity calibration of in vivo sensors used to measure analyte concentration
|
US7620438B2
(en)
|
2006-03-31 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for powering an electronic device
|
US8346335B2
(en)
|
2008-03-28 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US8224415B2
(en)
|
2009-01-29 |
2012-07-17 |
Abbott Diabetes Care Inc. |
Method and device for providing offset model based calibration for analyte sensor
|
US8473022B2
(en)
|
2008-01-31 |
2013-06-25 |
Abbott Diabetes Care Inc. |
Analyte sensor with time lag compensation
|
US7618369B2
(en)
|
2006-10-02 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for dynamically updating calibration parameters for an analyte sensor
|
US8140312B2
(en)
|
2007-05-14 |
2012-03-20 |
Abbott Diabetes Care Inc. |
Method and system for determining analyte levels
|
US8374668B1
(en)
|
2007-10-23 |
2013-02-12 |
Abbott Diabetes Care Inc. |
Analyte sensor with lag compensation
|
US8226891B2
(en)
|
2006-03-31 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods therefor
|
CA2648280C
(en)
*
|
2006-04-03 |
2014-03-11 |
Isa Odidi |
Controlled release delivery device comprising an organosol coat
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
US10960077B2
(en)
*
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
PL2026803T3
(pl)
*
|
2006-05-16 |
2012-05-31 |
Knopp Neurosciences Inc |
Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
|
US7920907B2
(en)
|
2006-06-07 |
2011-04-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and method
|
HUE032156T2
(en)
|
2006-06-19 |
2017-09-28 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical preparations
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8401654B1
(en)
|
2006-06-30 |
2013-03-19 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating one or more effects of deafferentation
|
US8504163B1
(en)
|
2006-06-30 |
2013-08-06 |
Boston Scientific Neuromodulation Corporation |
Cranially mounted stimulation systems and methods
|
WO2008079440A2
(en)
|
2006-07-10 |
2008-07-03 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
ATE510538T1
(de)
|
2006-08-11 |
2011-06-15 |
Univ Johns Hopkins |
Zusammensetzungen und verfahren für nervenschutz
|
CA2666814A1
(en)
*
|
2006-08-21 |
2008-05-29 |
United Therapeutics Corporation |
Combination therapy for treatment of viral infections
|
NZ601278A
(en)
|
2006-09-22 |
2013-09-27 |
Pharmacyclics Inc |
Inhibitors of Bruton's tyrosine kinase
|
US7445528B1
(en)
|
2006-09-29 |
2008-11-04 |
Boston Scientific Neuromodulation Corporation |
Connector assemblies
|
US8135548B2
(en)
|
2006-10-26 |
2012-03-13 |
Abbott Diabetes Care Inc. |
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
|
US7347746B1
(en)
|
2006-10-27 |
2008-03-25 |
Boston Scientific Neuromodulation Corporation |
Receptacle connector assembly
|
DE102006051625A1
(de)
*
|
2006-11-02 |
2008-05-08 |
Bayer Materialscience Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
EP2091482A2
(de)
|
2006-12-01 |
2009-08-26 |
Allergan, Inc. |
Verfahren zur bestimmung optimaler intraokularer standorte für systeme zur verabreichung von medikamenten
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
WO2008089260A2
(en)
*
|
2007-01-16 |
2008-07-24 |
Victory Pharma, Inc. |
Combined administration of benzonatate and guaifenesin
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US8121857B2
(en)
|
2007-02-15 |
2012-02-21 |
Abbott Diabetes Care Inc. |
Device and method for automatic data acquisition and/or detection
|
US20080199894A1
(en)
|
2007-02-15 |
2008-08-21 |
Abbott Diabetes Care, Inc. |
Device and method for automatic data acquisition and/or detection
|
US8732188B2
(en)
|
2007-02-18 |
2014-05-20 |
Abbott Diabetes Care Inc. |
Method and system for providing contextual based medication dosage determination
|
US8930203B2
(en)
|
2007-02-18 |
2015-01-06 |
Abbott Diabetes Care Inc. |
Multi-function analyte test device and methods therefor
|
US8123686B2
(en)
|
2007-03-01 |
2012-02-28 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing rolling data in communication systems
|
CA2681110A1
(en)
*
|
2007-03-14 |
2008-09-18 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
US10111608B2
(en)
|
2007-04-14 |
2018-10-30 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
CA2683930A1
(en)
|
2007-04-14 |
2008-10-23 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
CA2683721C
(en)
|
2007-04-14 |
2017-05-23 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
|
EP2146625B1
(de)
|
2007-04-14 |
2019-08-14 |
Abbott Diabetes Care Inc. |
Verfahren und gerät zur bereitstellung von datenverarbeitung und kontrolle in einem medizinischen kommunikationssystem
|
US9204827B2
(en)
|
2007-04-14 |
2015-12-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
EP2146624B1
(de)
|
2007-04-14 |
2020-03-25 |
Abbott Diabetes Care Inc. |
Verfahren und vorrichtung zur datenverarbeitung und steuerung in einem medizinischen kommunikationssystem
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
US8456301B2
(en)
|
2007-05-08 |
2013-06-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US7928850B2
(en)
|
2007-05-08 |
2011-04-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8665091B2
(en)
|
2007-05-08 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Method and device for determining elapsed sensor life
|
US8461985B2
(en)
|
2007-05-08 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8239166B2
(en)
|
2007-05-14 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8444560B2
(en)
|
2007-05-14 |
2013-05-21 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8600681B2
(en)
|
2007-05-14 |
2013-12-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US7996158B2
(en)
|
2007-05-14 |
2011-08-09 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8560038B2
(en)
|
2007-05-14 |
2013-10-15 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US10002233B2
(en)
|
2007-05-14 |
2018-06-19 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US9125548B2
(en)
|
2007-05-14 |
2015-09-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8103471B2
(en)
|
2007-05-14 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8260558B2
(en)
|
2007-05-14 |
2012-09-04 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US20200037875A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2008150917A1
(en)
|
2007-05-31 |
2008-12-11 |
Abbott Diabetes Care, Inc. |
Insertion devices and methods
|
US20080306434A1
(en)
|
2007-06-08 |
2008-12-11 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
EP3533387A3
(de)
|
2007-06-21 |
2019-11-13 |
Abbott Diabetes Care, Inc. |
Gesundheitsverwaltungsvorrichtungen und -verfahren
|
AU2008265542B2
(en)
|
2007-06-21 |
2014-07-24 |
Abbott Diabetes Care Inc. |
Health monitor
|
US8160900B2
(en)
|
2007-06-29 |
2012-04-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
|
US7768386B2
(en)
|
2007-07-31 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8834366B2
(en)
|
2007-07-31 |
2014-09-16 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor calibration
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
EP2200607A4
(de)
|
2007-09-10 |
2012-02-22 |
Calcimedica Inc |
Verbindungen als modulatoren von intrazellulärem calcium
|
US20090088681A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Mcintyre Jon T |
Device and method for the treatment of intra-abdominal disease
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
EP4159114B1
(de)
|
2007-10-09 |
2024-04-10 |
DexCom, Inc. |
Integriertes insulin-abgabesystem mit kontinuierlichem glucosesensor
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
US8216138B1
(en)
|
2007-10-23 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
|
US8409093B2
(en)
|
2007-10-23 |
2013-04-02 |
Abbott Diabetes Care Inc. |
Assessing measures of glycemic variability
|
US8377031B2
(en)
*
|
2007-10-23 |
2013-02-19 |
Abbott Diabetes Care Inc. |
Closed loop control system with safety parameters and methods
|
JP2011505520A
(ja)
*
|
2007-12-03 |
2011-02-24 |
メディパックス インコーポレイテッド |
流体計量供給装置
|
JP2011506319A
(ja)
|
2007-12-06 |
2011-03-03 |
デュレクト コーポレーション |
疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20090164239A1
(en)
|
2007-12-19 |
2009-06-25 |
Abbott Diabetes Care, Inc. |
Dynamic Display Of Glucose Information
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
KR20100136967A
(ko)
*
|
2008-02-15 |
2010-12-29 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
파열 효과가 감소된 방출 제어 경구 정제
|
CA2721214A1
(en)
|
2008-04-10 |
2009-10-15 |
Abbott Diabetes Care Inc. |
Method and system for sterilizing an analyte sensor
|
US8591410B2
(en)
|
2008-05-30 |
2013-11-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US8924159B2
(en)
|
2008-05-30 |
2014-12-30 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US7826382B2
(en)
|
2008-05-30 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Close proximity communication device and methods
|
WO2010009172A1
(en)
|
2008-07-14 |
2010-01-21 |
Abbott Diabetes Care Inc. |
Closed loop control system interface and methods
|
CA2734491A1
(en)
*
|
2008-08-19 |
2010-02-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (r)-pramipexole
|
BRPI0917719A2
(pt)
|
2008-08-27 |
2019-11-19 |
Calcimedica Inc |
compostos que modulam cálcio intracelular
|
US8734422B2
(en)
|
2008-08-31 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Closed loop control with improved alarm functions
|
US20100057040A1
(en)
|
2008-08-31 |
2010-03-04 |
Abbott Diabetes Care, Inc. |
Robust Closed Loop Control And Methods
|
US8622988B2
(en)
|
2008-08-31 |
2014-01-07 |
Abbott Diabetes Care Inc. |
Variable rate closed loop control and methods
|
US9943644B2
(en)
|
2008-08-31 |
2018-04-17 |
Abbott Diabetes Care Inc. |
Closed loop control with reference measurement and methods thereof
|
US8986208B2
(en)
|
2008-09-30 |
2015-03-24 |
Abbott Diabetes Care Inc. |
Analyte sensor sensitivity attenuation mitigation
|
EP2341924A4
(de)
|
2008-10-02 |
2013-01-23 |
David Gladstone Inst |
Verfahren zur behandlung von hepatitis-c-virusinfektionen
|
US20100104654A1
(en)
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US9326707B2
(en)
|
2008-11-10 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Alarm characterization for analyte monitoring devices and systems
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
DE102008059206A1
(de)
|
2008-11-27 |
2010-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US8103456B2
(en)
|
2009-01-29 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and device for early signal attenuation detection using blood glucose measurements
|
ES2747755T3
(es)
|
2009-01-29 |
2020-03-11 |
Forsight Vision4 Inc |
Administración de un fármaco al segmento posterior
|
US20100198034A1
(en)
|
2009-02-03 |
2010-08-05 |
Abbott Diabetes Care Inc. |
Compact On-Body Physiological Monitoring Devices and Methods Thereof
|
US20100204325A1
(en)
|
2009-02-11 |
2010-08-12 |
Allergan, Inc. |
Valproic acid drug delivery systems and intraocular therapeutic uses thereof
|
JP2012520884A
(ja)
|
2009-03-18 |
2012-09-10 |
ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー |
フラビウイルス科ウイルス感染症を治療する方法および組成物
|
US8497777B2
(en)
|
2009-04-15 |
2013-07-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring system having an alert
|
EP2419015A4
(de)
|
2009-04-16 |
2014-08-20 |
Abbott Diabetes Care Inc |
Kalibrierung eines analytsensors
|
WO2010124296A2
(en)
|
2009-04-24 |
2010-10-28 |
Tissuetech, Inc. |
Compositions containing hc•ha complex and methods of use thereof
|
WO2010127050A1
(en)
|
2009-04-28 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Error detection in critical repeating data in a wireless sensor system
|
EP2425209A4
(de)
|
2009-04-29 |
2013-01-09 |
Abbott Diabetes Care Inc |
Verfahren und system für die echtzeit-kalibrierung eines analytsensors mit rückwirkender füllung
|
WO2010127187A1
(en)
|
2009-04-29 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
US20100278897A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Intraocular bioactive agent delivery system with molecular partitioning system
|
US8372036B2
(en)
*
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
WO2010138856A1
(en)
|
2009-05-29 |
2010-12-02 |
Abbott Diabetes Care Inc. |
Medical device antenna systems having external antenna configurations
|
BRPI0925100A2
(pt)
|
2009-06-02 |
2016-07-19 |
Dow Global Technologies Llc |
forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
EP2442655A4
(de)
*
|
2009-06-19 |
2013-04-03 |
Knopp Neurosciences Inc |
Zusammensetzungen und verfahren zur behandlung von amyotropher lateralsklerose (als)
|
US8613892B2
(en)
|
2009-06-30 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Analyte meter with a moveable head and methods of using the same
|
DK3689237T3
(da)
|
2009-07-23 |
2021-08-16 |
Abbott Diabetes Care Inc |
Fremgangsmåde til fremstilling og system til kontinuerlig analytmåling
|
WO2011014851A1
(en)
|
2009-07-31 |
2011-02-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte monitoring system calibration accuracy
|
WO2011021594A1
(ja)
*
|
2009-08-18 |
2011-02-24 |
国立大学法人東北大学 |
持続性ドラッグデリバリーシステム
|
ES2959131T3
(es)
|
2009-08-31 |
2024-02-20 |
Abbott Diabetes Care Inc |
Visualizadores para un dispositivo médico
|
US8993331B2
(en)
|
2009-08-31 |
2015-03-31 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods for managing power and noise
|
EP3001194B1
(de)
|
2009-08-31 |
2019-04-17 |
Abbott Diabetes Care, Inc. |
Medizinische vorrichtungen und verfahren
|
US9314195B2
(en)
|
2009-08-31 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Analyte signal processing device and methods
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
DE102009042855A1
(de)
*
|
2009-09-24 |
2011-03-31 |
Pfenning Elektroanlagen Gmbh |
Portalhubwagen zum Einsatz in Containerterminals und für allgemeine Transportaufgaben
|
US9320461B2
(en)
|
2009-09-29 |
2016-04-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing notification function in analyte monitoring systems
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
WO2011053881A1
(en)
|
2009-10-30 |
2011-05-05 |
Abbott Diabetes Care Inc. |
Method and apparatus for detecting false hypoglycemic conditions
|
WO2011057129A2
(en)
|
2009-11-09 |
2011-05-12 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
EP2512389B1
(de)
|
2009-12-16 |
2015-09-02 |
Allergan, Inc. |
Intrakamerale vorrichtungen für verzögerte freisetzung
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
US20110172637A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Drug delivery device including tissue support structure
|
US20110172609A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
US20110172639A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Device and method for delivery of microneedle to desired depth within the skin
|
US20110172645A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Wearable drug delivery device including integrated pumping and activation elements
|
USD924406S1
(en)
|
2010-02-01 |
2021-07-06 |
Abbott Diabetes Care Inc. |
Analyte sensor inserter
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
WO2011112753A1
(en)
|
2010-03-10 |
2011-09-15 |
Abbott Diabetes Care Inc. |
Systems, devices and methods for managing glucose levels
|
CN102639185B
(zh)
|
2010-03-24 |
2015-02-04 |
雅培糖尿病护理公司 |
医疗装置插入物以及插入和使用医疗装置的方法
|
TR201802207T4
(tr)
|
2010-03-29 |
2018-03-21 |
Astellas Pharma Inc |
Kontrollü Salımlı Farmasötik Bileşim.
|
EP2558866B1
(de)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potenzierung einer antikrebs-wirkung durch eine kombinationstherapie mit ber-pfad-hemmern
|
EP2563776B1
(de)
|
2010-04-27 |
2016-06-08 |
Calcimedica, Inc. |
Verbindungen als modulatoren von intrazellulärem calcium
|
US8754219B2
(en)
|
2010-04-27 |
2014-06-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CA3007787C
(en)
|
2010-06-03 |
2020-03-10 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
US8635046B2
(en)
|
2010-06-23 |
2014-01-21 |
Abbott Diabetes Care Inc. |
Method and system for evaluating analyte sensor response characteristics
|
US11064921B2
(en)
|
2010-06-29 |
2021-07-20 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US10092229B2
(en)
|
2010-06-29 |
2018-10-09 |
Abbott Diabetes Care Inc. |
Calibration of analyte measurement system
|
EP2600876B1
(de)
|
2010-08-05 |
2015-04-29 |
Forsight Vision4, Inc. |
Verfahren und vorrichtung zur verabreichung kombinierter arzneimittel
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
SI2600930T1
(sl)
|
2010-08-05 |
2021-08-31 |
Forsight Vision4, Inc. |
Injekcijska naprava za dajanje zdravila
|
MX337711B
(es)
|
2010-08-27 |
2016-03-15 |
Calcimedica Inc |
Compuestos que modulan el calcio intracelular.
|
US11213226B2
(en)
|
2010-10-07 |
2022-01-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods
|
US8668675B2
(en)
|
2010-11-03 |
2014-03-11 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US8518440B2
(en)
|
2010-12-21 |
2013-08-27 |
Confluent Surgical, Inc. |
Biodegradable osmotic pump implant for drug delivery
|
EP3042654A1
(de)
|
2011-01-20 |
2016-07-13 |
Bionevia Pharmaceuticals Inc. |
Zusammensetzungen mit veränderter freisetzung von epalrestat oder einem derivat davon und verwendungsverfahren dafür
|
US8801768B2
(en)
*
|
2011-01-21 |
2014-08-12 |
Endologix, Inc. |
Graft systems having semi-permeable filling structures and methods for their use
|
US10136845B2
(en)
|
2011-02-28 |
2018-11-27 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
CN107019515B
(zh)
|
2011-02-28 |
2021-02-26 |
雅培糖尿病护理公司 |
显示传感器读数的方法与分析物监测装置及其操作方法
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
WO2012142502A2
(en)
|
2011-04-15 |
2012-10-18 |
Dexcom Inc. |
Advanced analyte sensor calibration and error detection
|
US9526770B2
(en)
|
2011-04-28 |
2016-12-27 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
CA2837878A1
(en)
|
2011-06-10 |
2012-12-13 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
EP2720539B1
(de)
|
2011-06-14 |
2018-10-24 |
Bikam Pharmaceuticals, Inc. |
Opsinbindende liganden, deren zusammensetzungen und anwendungsverfahren
|
WO2012175698A1
(en)
|
2011-06-23 |
2012-12-27 |
Université Libre de Bruxelles |
Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
|
EP2726016B1
(de)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
CA2841785A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
EP2739252A4
(de)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
Abgabe kleiner moleküle über eine implantierbare therapeutische vorrichtung
|
EP3222720A1
(de)
|
2011-09-01 |
2017-09-27 |
University of Southern California |
Verfahren zur herstellung von hochdurchsatzpeptidomimetika, oral bioverfügbaren wirkstoffen und zusammensetzungen damit
|
US9492423B2
(en)
|
2011-09-13 |
2016-11-15 |
Pharmacyclics Llc |
Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013066849A1
(en)
|
2011-10-31 |
2013-05-10 |
Abbott Diabetes Care Inc. |
Model based variable risk false glucose threshold alarm prevention mechanism
|
US9069536B2
(en)
|
2011-10-31 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Electronic devices having integrated reset systems and methods thereof
|
AU2012335830B2
(en)
|
2011-11-07 |
2017-05-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods
|
US8710993B2
(en)
|
2011-11-23 |
2014-04-29 |
Abbott Diabetes Care Inc. |
Mitigating single point failure of devices in an analyte monitoring system and methods thereof
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9317656B2
(en)
|
2011-11-23 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
|
EP3936133A1
(de)
|
2011-11-23 |
2022-01-12 |
TherapeuticsMD, Inc. |
Natürliche kombinationshormonersatzformulierungen und therapien
|
WO2013078426A2
(en)
|
2011-11-25 |
2013-05-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods of use
|
JP6126118B2
(ja)
|
2011-11-30 |
2017-05-10 |
ビカム ファーマスーティカルス,インコーポレイテッド |
オプシン結合性リガンド、組成物、及び使用方法
|
BR112014013106A2
(pt)
|
2011-12-01 |
2017-06-13 |
Bikam Pharmaceuticals Inc |
ligantes de ligação à opsina, composições e métodos de uso
|
SG11201402899TA
(en)
|
2011-12-06 |
2014-07-30 |
Univ Leland Stanford Junior |
Methods and compositions for treating viral diseases
|
EP4344633A2
(de)
|
2011-12-11 |
2024-04-03 |
Abbott Diabetes Care, Inc. |
Analytsensorvorrichtungen, verbindungen und verfahren
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
EP3698782A1
(de)
|
2012-01-06 |
2020-08-26 |
Lundbeck La Jolla Research Center, Inc. |
Carbamatverbindungen zur verwendung in therapie
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP2814514B1
(de)
|
2012-02-16 |
2017-09-13 |
Atyr Pharma, Inc. |
Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
|
JP2015510956A
(ja)
|
2012-03-14 |
2015-04-13 |
メディパックス インコーポレイテッド |
過剰反応性分子を含むスマートポリマー材料
|
MX2014013320A
(es)
|
2012-05-07 |
2015-08-10 |
Bayer Pharma AG |
Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
|
MY187999A
(en)
|
2012-06-04 |
2021-11-08 |
Pharmacyclics Llc |
Crystalline forms of a bruton's tyrosine kinase inhibitor
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
UY34856A
(es)
|
2012-07-03 |
2013-12-31 |
Bayer Pharma AG |
Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
|
JP2015528001A
(ja)
|
2012-07-11 |
2015-09-24 |
ティッシュテック,インク. |
Hc−ha/ptx3複合体を含む組成物およびその使用方法
|
EP3395252A1
(de)
|
2012-08-30 |
2018-10-31 |
Abbott Diabetes Care, Inc. |
Ausfallerkennung bei kontinuierlichen analytüberwachungsdaten bei datenabweichungen
|
US9968306B2
(en)
|
2012-09-17 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
|
EP2901153A4
(de)
|
2012-09-26 |
2016-04-27 |
Abbott Diabetes Care Inc |
Verfahren und vorrichtung zur verbesserung einer verzögerungskorrekturfunktion während der in-vivo-messung einer analytkonzentration mit analytkonzentrationsvariabilität und bereichsdaten
|
CA2885828C
(en)
|
2012-09-28 |
2021-04-27 |
University Of Washington Through Its Center For Commercialization |
Ureido-thiophenyl derivatives, compositions thereof and methods for preventing, treating and/or protecting against sensory hair cell death
|
US9717741B2
(en)
|
2012-10-11 |
2017-08-01 |
Anaplasi Pharmaceuticals Llc |
Method and compositions for treating psoriasis
|
WO2014058427A1
(en)
|
2012-10-11 |
2014-04-17 |
Anaplasi Pharmaceuticals Llc |
Method and compositions for treating psoriasis
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
GB2510826B
(en)
|
2013-02-13 |
2015-09-02 |
Animax Ltd |
Improvements in or relating to release of a beneficial substance from a bolus
|
WO2014127243A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
WO2014152034A1
(en)
|
2013-03-15 |
2014-09-25 |
Abbott Diabetes Care Inc. |
Sensor fault detection using analyte sensor data pattern comparison
|
US9474475B1
(en)
|
2013-03-15 |
2016-10-25 |
Abbott Diabetes Care Inc. |
Multi-rate analyte sensor data collection with sample rate configurable signal processing
|
US10433773B1
(en)
|
2013-03-15 |
2019-10-08 |
Abbott Diabetes Care Inc. |
Noise rejection methods and apparatus for sparsely sampled analyte sensor data
|
JP6385423B2
(ja)
|
2013-03-28 |
2018-09-05 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
治療物質送達用の眼移植片
|
WO2015006708A1
(en)
|
2013-07-12 |
2015-01-15 |
Knopp Biosciences Llc |
Treating elevated levels of eosinophils and/or basophils
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
AU2014306597B2
(en)
|
2013-08-13 |
2018-05-17 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
US9642840B2
(en)
|
2013-08-13 |
2017-05-09 |
Knopp Biosciences, Llc |
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
|
WO2015054283A1
(en)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
BR112016012728A2
(pt)
|
2013-12-05 |
2020-08-11 |
Pharmacyclics Llc |
compostos inibidores de tirosina quinase de bruton, composição farmacêutica os compreendendo e uso dos mesmos
|
WO2015102745A1
(en)
|
2013-12-31 |
2015-07-09 |
Abbott Diabetes Care Inc. |
Self-powered analyte sensor and devices using the same
|
EP3125761B1
(de)
|
2014-03-30 |
2020-09-30 |
Abbott Diabetes Care Inc. |
Verfahren und vorrichtung zur bestimmung des starts einer mahlzeit und von spitzenwertereignissen in analytüberwachungssystemen
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
KR20170005819A
(ko)
|
2014-05-22 |
2017-01-16 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
천연 복합 호르몬 대체 제형 및 요법
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
CN106687079B
(zh)
|
2014-07-15 |
2019-10-11 |
弗赛特影像4股份有限公司 |
眼睛植入输送装置和方法
|
WO2016016770A1
(en)
|
2014-07-26 |
2016-02-04 |
Wockhardt Limited |
A novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
SG11201703726XA
(en)
|
2014-11-10 |
2017-06-29 |
Forsight Vision4 Inc |
Expandable drug delivery devices and method of use
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10213586B2
(en)
|
2015-01-28 |
2019-02-26 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
US10399994B2
(en)
|
2015-02-06 |
2019-09-03 |
University Of Washington |
Compounds and methods for preventing or treating sensory hair cell death
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
US9579289B2
(en)
|
2015-02-20 |
2017-02-28 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release dosage form
|
WO2016138025A2
(en)
|
2015-02-23 |
2016-09-01 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
EA039121B1
(ru)
|
2015-02-27 |
2021-12-07 |
Куртана Фармасьютикалс, Инк. |
ИНГИБИРОВАНИЕ АКТИВНОСТИ Olig2
|
TW202315634A
(zh)
|
2015-03-03 |
2023-04-16 |
美商製藥公司 |
布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
MA41827A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
|
MA41828A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
|
US10575976B2
(en)
|
2015-04-30 |
2020-03-03 |
Dynamic Mouth Devices, L.L.C. |
Method and apparatus for weight management utilizing an intra-oral device
|
CA2984480A1
(en)
|
2015-05-11 |
2016-11-17 |
Abide Therapeutics, Inc. |
Methods of treating inflammation or neuropathic pain
|
US10213139B2
(en)
|
2015-05-14 |
2019-02-26 |
Abbott Diabetes Care Inc. |
Systems, devices, and methods for assembling an applicator and sensor control device
|
WO2016183493A1
(en)
|
2015-05-14 |
2016-11-17 |
Abbott Diabetes Care Inc. |
Compact medical device inserters and related systems and methods
|
CN107847526A
(zh)
|
2015-05-20 |
2018-03-27 |
组织技术公司 |
用于预防上皮细胞的增殖和上皮‑间充质转换的组合物和方法
|
CN108024765B
(zh)
|
2015-07-10 |
2021-06-11 |
雅培糖尿病护理公司 |
对于生理参数进行动态葡萄糖曲线响应的系统、装置和方法
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
CA2993009A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
WO2017040617A1
(en)
|
2015-08-31 |
2017-03-09 |
Pharmacyclics Llc |
Btk inhibitor combinations for treating multiple myeloma
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
KR20180084104A
(ko)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
연장 방출 약물 전달 장치를 위한 다공성 구조물
|
ES2952064T3
(es)
|
2015-12-16 |
2023-10-26 |
Walter & Eliza Hall Inst Medical Res |
Inhibición de la proteína SH2 inducida por citocinas en células NK
|
EP3405178A1
(de)
|
2016-01-19 |
2018-11-28 |
Janssen Pharmaceutica NV |
Formulierungen/zusammensetzungen mit einem btk-inhibitoren
|
EA201891440A1
(ru)
|
2016-01-19 |
2018-12-28 |
Янссен Фармацевтика Нв |
Составы/композиции, содержащие ингибитор btk
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
JP7049683B2
(ja)
|
2016-04-04 |
2022-04-07 |
シノピア バイオサイエンシーズ,インク. |
トラピジルを使用する錐体外路症候群の処置
|
WO2017176886A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
WO2017205534A1
(en)
|
2016-05-25 |
2017-11-30 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
DK3484862T3
(da)
|
2016-07-18 |
2021-11-08 |
Arthrosi Therapeutics Inc |
Forbindelser, sammensætninger og fremgangsmåder til behandling eller forebyggelse af et symptom, der er forbundet med gigt eller hyperurikæmi
|
KR102468670B1
(ko)
|
2016-08-26 |
2022-11-17 |
커타나 파마슈티칼스, 인크. |
Olig2 활성의 억제
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
ES2900016T3
(es)
|
2016-11-16 |
2022-03-15 |
H Lundbeck As |
Una forma cristalina de un inhibidor de MAGL
|
JP2020500176A
(ja)
|
2016-11-16 |
2020-01-09 |
ルンドベック ラ ホーヤ リサーチ センター,インク. |
医薬製剤
|
US11564982B2
(en)
|
2017-01-04 |
2023-01-31 |
Research Institute At Nationwide Children's Hospital |
DNABII vaccines and antibodies with enhanced activity
|
AU2018206560A1
(en)
|
2017-01-04 |
2019-07-18 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
AU2018205529B2
(en)
|
2017-01-06 |
2023-08-10 |
Morningside Venture Investments Limited |
Transdermal drug delivery devices and methods
|
CN110461217B
(zh)
|
2017-01-23 |
2022-09-16 |
雅培糖尿病护理公司 |
用于分析物传感器插入的系统、装置和方法
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
WO2018175489A1
(en)
|
2017-03-21 |
2018-09-27 |
Abbott Diabetes Care Inc. |
Methods, devices and system for providing diabetic condition diagnosis and therapy
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
AU2018325267B2
(en)
|
2017-09-01 |
2023-03-30 |
University Of Washington |
Crystalline forms of compounds for preventing or treating sensory hair cell death
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
CN212438615U
(zh)
|
2017-10-24 |
2021-02-02 |
德克斯康公司 |
可穿戴设备
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
SG11202007825XA
(en)
|
2018-02-16 |
2020-09-29 |
Esperion Therapeutics Inc |
Sustained release formulations of bempedoic acid
|
JP7044416B2
(ja)
|
2018-02-28 |
2022-03-30 |
シャンハイ ダブリュディー ファーマシューティカル カンパニー,リミティド |
薬物組成物およびその製造方法と使用
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
CA3090183C
(en)
|
2018-03-05 |
2021-06-01 |
Kashiv Biosciences, Llc |
Programmable pharmaceutical compositions for chrono drug release
|
EP3797818B1
(de)
|
2018-05-23 |
2023-01-18 |
Shanghai WD Pharmaceutical Co., Ltd |
System zur verzögerten freisetzung eines wirkstoffes und verfahren zu seiner herstellung
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
WO2020020790A1
(de)
|
2018-07-24 |
2020-01-30 |
Bayer Aktiengesellschaft |
Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
|
CN112469402A
(zh)
|
2018-07-24 |
2021-03-09 |
拜耳公司 |
可口服给药且缓释的药物剂型
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
TW202019887A
(zh)
|
2018-07-27 |
2020-06-01 |
美商同心止痛劑股份有限公司 |
酚系trpv1促效劑之聚乙二醇化前藥
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
EP3937938A1
(de)
|
2019-03-15 |
2022-01-19 |
Unicycive Therapeutics Inc. |
Nicorandilderivate
|
USD1002852S1
(en)
|
2019-06-06 |
2023-10-24 |
Abbott Diabetes Care Inc. |
Analyte sensor device
|
EP3750528A1
(de)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Zusammensetzungen zur behandlung von dystrophien und myotonie
|
CA3145385A1
(en)
|
2019-07-08 |
2021-01-14 |
Steven D. Goodman |
Antibody compositions for disrupting biofilms
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
JP2023523219A
(ja)
|
2020-04-21 |
2023-06-02 |
ハー・ルンドベック・アクチエゼルスカベット |
モノアシルグリセロールリパーゼ阻害剤の合成
|
CA3186425A1
(en)
|
2020-06-10 |
2021-12-16 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
USD999913S1
(en)
|
2020-12-21 |
2023-09-26 |
Abbott Diabetes Care Inc |
Analyte sensor inserter
|
CA3204457A1
(en)
|
2021-01-06 |
2022-07-14 |
Ben SESSA |
Mdma in the treatment of alcohol use disorder
|
WO2022238507A1
(en)
|
2021-05-11 |
2022-11-17 |
Awakn Ls Europe Holdings Limited |
Therapeutic aminoindane compounds and compositions
|
WO2022247952A1
(zh)
*
|
2021-05-28 |
2022-12-01 |
上海博志研新药物技术有限公司 |
硝苯地平美托洛尔缓释组合物、其制备方法及应用
|
CA3221280A1
(en)
|
2021-06-03 |
2022-12-08 |
Arcadia Medicine, Inc. |
Enantiomeric entactogen compositions and methods of their use
|
AU2022325861A1
(en)
|
2021-08-11 |
2024-02-29 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
AU2022331496A1
(en)
|
2021-08-20 |
2024-02-29 |
Biomea Fusion, Inc. |
Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
US11945785B2
(en)
|
2021-12-30 |
2024-04-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of FLT3
|
WO2023139163A1
(en)
|
2022-01-19 |
2023-07-27 |
Awakn Ls Europe Holdings Limited |
1,3-benzodioxole esters and their therapeutic use
|
CN115490316B
(zh)
*
|
2022-01-24 |
2023-09-12 |
成都理工大学 |
一种可再利用的地下水营养物质缓释胶囊体
|
WO2023156565A1
(en)
|
2022-02-16 |
2023-08-24 |
Awakn Ls Europe Holdings Limited |
Bridged ring compounds and their therapeutic use as cns agents
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
WO2023240186A1
(en)
|
2022-06-08 |
2023-12-14 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|
US20240010649A1
(en)
|
2022-07-06 |
2024-01-11 |
Oppilan Pharma Limited |
Crystalline forms of an s1p receptor modulator
|
US11931224B1
(en)
*
|
2022-12-19 |
2024-03-19 |
Robert Parker |
Tooth pod
|